Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes

• Główni autorzy: Hadi Rajabi (Autor), Mahdi Ahmadi (Autor), Somayeh Aslani (Autor), Shirin Saberianpour (Autor), Reza Rahbarghazi (Autor)
• Format: Książka
• Wydane: Tabriz University of Medical Sciences, 2022-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further resear...